Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
23.34
-0.67 (-2.79%)
Jul 28, 2026, 12:23 PM EDT - Market open
Sutro Biopharma Employees
Sutro Biopharma had 133 employees as of March 31, 2026. The number of employees decreased by 4 or -2.92% since the number was last reported on December 31, 2025.
Employees
133
Change
-4
Growth
-2.92%
Revenue / Employee
$748,932
Profits / Employee
-$1,154,902
Market Cap
386.75M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 133 | -4 | -2.92% |
| Dec 31, 2025 | 137 | -173 | -55.81% |
| Dec 31, 2024 | 310 | 8 | 2.65% |
| Dec 31, 2023 | 302 | 24 | 8.63% |
| Dec 31, 2022 | 278 | 54 | 24.11% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Capricor Therapeutics | 231 |
| Puma Biotechnology | 179 |
| C4 Therapeutics | 104 |
| Editas Medicine | 87 |
| Prelude Therapeutics | 79 |
| Larimar Therapeutics | 71 |
| Atea Pharmaceuticals | 55 |
STRO News
- 6 weeks ago - Sutro Biopharma assumed with a Buy at Truist - TheFly
- 7 weeks ago - Sutro Biopharma Transcript: AGM 2026 - Transcripts
- 7 weeks ago - Sutro Biopharma Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Sutro Biopharma initiated with an Overweight at Barclays - TheFly
- 2 months ago - Sutro Biopharma Transcript: 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA - Transcripts
- 2 months ago - Sutro Biopharma price target raised to $10 from $9 at BofA - TheFly
- 2 months ago - Wedbush upgrades Sutro Biopharma to Outperform, raises price target to $60 - TheFly
- 2 months ago - Sutro Biopharma upgraded to Outperform from Neutral at Wedbush - TheFly